FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

HCLTECH Share Price Discussion

HCL Technologies Ltd.
NSE: HCLTECH | BSE: 532281 | ISIN: INE860A01027 | Sector: Information Technology
Find answers to all your questions on live HCLTECH message board: Is HCLTECH buy or sell? Should I buy HCLTECH shares? Why are HCLTECH shares falling? Should I invest in HCLTECH stock?

You can also check HCLTECH share price target recommended by brokerages.
@hidden • Reputation: 4,267
HIDDEN GEM in HCLTECH
LIVE CALL SELL HCL TECH 1123-1128....SL 1138......

HCL TECH 1112......PARTY ON THE ROCKS
NO IF NO BUT ONLY SURESHOT 💎💎💎💎💎💎💎
Like
reply
Reply
Recent posts in HCLTECH

Futures & Options educational trades for the week 24.2.20 to 28.2.20*
(My trade rules apply)
Hcltech* cmp 608.35 buy upto 593.00 stop 584.00 target 634.00+
Like
reply
Reply
@sagaani • Reputation: -16,172

1ST TARGET DONE
BUY HCL TECH 606.4 TARGET 612_618_624 STOPLOSS 601.55 SAFE TARDERS CAN EXIT AT 604.05
FROM 606.4 TO 612 GIVING RS. 5.6 PER SHARE PROFIT
HAPPY TRADING
Like
reply
Reply
@100billionclub • Reputation: 3,727
Billion Club in HCLTECH
SELL HCLTECH FEB BELOW 611

ONCE EXIT SHORT IN HCLTECH AT 607.20. BOOK PROFIT RS. 5,320
Like
reply
Reply
@commodityBiz • Reputation: 17,344

HCLTECH - chart - 614554
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 610 WITH SL OF 612 FOR TARGET OF 600
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@newsbot • Reputation: 2,308
Data watch | Nine companies posted double-digit topline growth in last 4 quarters
The list includes majorly healthcare and IT companies - stocks like Apollo Hospitals, Aurobindo Pharma, Biocon, HCL Technologies and Info Edge.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Data-watch | These 9 companies consistently posted double-digit top line growth in last 4 quarters
The list includes majorly healthcare and IT companies - stocks like Apollo Hospitals, Aurobindo Pharma, Biocon, HCL Technologies and Info Edge.
Moneycontrol
Like
reply
Reply